MIGUEL ANGEL MORENO-PELAYO

HEAD OF DEPARTMENT

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Medical Science Medical Science professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Miguel Angel Moreno-Pelayo is the Head of Department at Hospital Ramón y Cajal-IRYCIS-CIBERER in Spain. His research focuses on genetic factors related to hearing impairment, including the evaluation of pathogenic variants and their implications in non-syndromic hearing loss. Recent publications highlight his work on genes such as GATA3, PIK3CA, and STRC, contributing significant insights into the pathophysiology of hearing disorders.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (16)

Guy Van Camp

Professor

University of Antwerp

BELGIUM

MIGUEL ANGEL MORENO-PELAYO

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

De Novo Heterozygous GATA3 Missense Variant Causes an Unexpected Phenotype of Non-Syndromic Hearing Impairment with Apparently Recessive Inheritance

Constitutional Mutation of PIK3CA: A Variant of Cowden Syndrome?

Novel Cases of Non-Syndromic Hearing Impairment Caused by Pathogenic Variants in Genes Encoding Mitochondrial Aminoacyl-tRNA Synthetases

Genetic Evaluation of Prelingual Hearing Impairment: Recommendations of an European Network for Genetic Hearing Impairment

Insights into the pathophysiology of DFNA44 hearing loss associated with CCDC50 frameshift variants

Cingulin regulates hair cell cuticular plate morphology and is required for hearing in human and mouse

Novel Pathogenic Variants in the Gene Encoding Stereocilin (STRC) Causing Non-Syndromic Moderate Hearing Loss in Spanish and Argentinean Subjects

Novel Pathogenic Variants in PJVK, the Gene Encoding Pejvakin, in Subjects with Autosomal Recessive Non-Syndromic Hearing Impairment and Auditory Neuropathy Spectrum Disorder

CRISPR/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts

Genetic etiology of non-syndromic hearing loss in Europe

Therapeutic Potential of <i>EWSR1–FLI1</i> Inactivation by CRISPR/Cas9 in Ewing Sarcoma

Collaborators (16)

Guy Van Camp

Anne-Francoise Roux

Neil Jon Ingham

Dominika Oziębło

Silvia Dossena

Helena Caria

Giorgia Girotto

Carlos Rodríguez-Martín

An Boudewyns

Alessandro Martini

Patrizia Mancini

Sebastian Roesch

Susanna Balcells

Saba Battelino

Katarina Trebušak Podkrajšek

Karen P. Steel

Make your next move.